Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 27, 2020, Aimmune Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on three proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 9, 2020. Only stockholders of record as of the close of business on March 31, 2020, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 65,222,917 shares of the Company's common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:

Proposal 1. The election of three directors to hold office until the 2023 annual meeting of stockholders or until their respective successor is elected:





Nominee              Votes For     Votes Withheld   Broker Non-Votes
Mark McDade         34,480,200      10,675,109         10,070,278
Dr. Brett Haumann   36,938,323       8,216,986         10,070,278
Stacey Seltzer      36,922,814       8,232,495         10,070,278

Proposal 2. The ratification of the selection, by the audit committee of the board of directors of the Company, of KPMG, LLP, as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2020:






Votes For    Votes Against   Abstentions
55,074,795      99,299         51,493

As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.

Proposal 3. The approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers:





                                             Broker
Votes For    Votes Against   Abstentions   Non-Votes
44,271,521      798,783        85,005      10,070,278

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses